BioSpace News Archive

Foresee Pharmaceuticals, announced that the company presented the positive primary outcomes of its aderamastat Phase 2 proof-of-concept allergic asthma study at the European Respiratory Society International Congress 2023 taking place in Milan, Italy from September 9-13, 2023.

Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in China: Unlocking the Potential of Advanced Therapies.

Arcus Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted eight new employees options to purchase a total of 35,400 shares of the Company’s common stock at an exercise price per share of $21.38, which was the closing price on September 8, 2023, and restricted stock units to acquire a total of 17,700 shares of the Company’s common stock.